Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
Background: Osteosarcoma is the most common primary bone tumor in childhood and adolescence. Carboplatin, a platinum-derived agent, is used as neoadjuvant chemotherapy for pediatric osteosarcoma because of its anti-tumor activity and had low toxicity as compared to cisplatin. Objective: To determine...
Saved in:
Main Authors: | Choeyprasert W., Natesirinilkul R., Charoenkwan P., Sittipreechacharn S. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84877637233&partnerID=40&md5=21f376b6973df83452e93859acac887e http://www.ncbi.nlm.nih.gov/pubmed/23621194 http://cmuir.cmu.ac.th/handle/6653943832/4067 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
by: Worawut Choeyprasert, et al.
Published: (2018) -
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: A 9-year single institute experience in the northern region of Thailand
by: Worawut Choeyprasert, et al.
Published: (2018) -
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: The role of high-dose methotrexate (HDMTX) in a single institute experience
by: Choeyprasert,W., et al.
Published: (2015) -
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: The role of high-dose methotrexate (HDMTX) in a single institute experience
by: Worawut Choeyprasert, et al.
Published: (2018) -
Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: A single institution experience from Thailand
by: Ekkasit Tharavichitkul, et al.
Published: (2018)